4 Reasons the Biosimilar Boom Could Save Your Clients $232 Billion
PBM Reform at Midyear 2026: Litigation and Legislative Updates for Self-Insured Plan Sponsors
10 Most Expensive Drugs in the U.S.: 2026 Edition
RxBenefits Receives Two Honorable Mentions at Ragan PR Daily Marketing Award
5 Questions Benefits Advisors Should Ask Before Recommending a PBM Switch
3 Warning Signs That You’re Overpaying for Specialty Drugs
PBM Legislative Updates Employers Should Watch in 2026
Biosimilars in Pharmacy Benefits: Why Formularies Must Evolve
Get Our Newsletter
Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.
